InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Olema Pharmaceuticals, Inc.

OLMA Clue Score20
United States Fiscal year ends December CIK 0001750284 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Shawnte Mitchell
4 Mar 2026
Chief Legal Officer
Sold after exercise
233
$24.69
$5.75K
Shawnte Mitchell
4 Mar 2026
Chief Legal Officer
Sold after exercise
24,767
$24.25
$600.60K
Shawnte Mitchell
3 Mar 2026
Chief Legal Officer
Sold after exercise
15,000
$23.01
$345.15K
David C. Myles
14 Jan 2026
Ch. Discov. & Non-Clin Dev Off
Sold after exercise
35,003
$28.99
$1.01M
David C. Myles
14 Jan 2026
Ch. Discov. & Non-Clin Dev Off
Sold after exercise
14,997
$28.60
$428.91K
David C. Myles
13 Jan 2026
Ch. Discov. & Non-Clin Dev Off
Sold after exercise
200
$28.49
$5.70K
David C. Myles
13 Jan 2026
Ch. Discov. & Non-Clin Dev Off
Sold after exercise
49,800
$27.60
$1.37M
Naseem Zojwalla
23 Dec 2025
Chief Medical Officer
Sold after exercise
99,509
$27.66
$2.75M
Naseem Zojwalla
22 Dec 2025
Chief Medical Officer
Sold after exercise
100,000
$28.04
$2.80M
Naseem Zojwalla
19 Dec 2025
Chief Medical Officer
Sold after exercise
12,921
$28.93
$373.80K
Naseem Zojwalla
19 Dec 2025
Chief Medical Officer
Sold after exercise
57,079
$28.03
$1.60M
Ian T Clark
19 Dec 2025
Director
Sold after exercise
41,840
$30.48
$1.28M
Ian T Clark
19 Dec 2025
Director
Sold after exercise
193,056
$29.71
$5.74M
Ian T Clark
19 Dec 2025
Director
Sold after exercise
29,904
$28.83
$862.13K
Show all 26 transactions →

What was left out

Form 4 filings counted 32
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 14
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 945,736
History held since 19 Nov 2020